Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.02% |
| Dec 31, 2025 | -2.17% |
| Sep 30, 2025 | 3.20% |
| Jun 30, 2025 | 2.26% |
| Mar 31, 2025 | 2.33% |
| Dec 31, 2024 | 2.16% |
| Sep 30, 2024 | -2.98% |
| Jun 30, 2024 | -16.69% |
| Mar 31, 2024 | 10.54% |
| Dec 31, 2023 | -13.80% |
| Sep 30, 2023 | -5.16% |
| Jun 30, 2023 | -11.45% |
| Mar 31, 2023 | -24.65% |
| Dec 31, 2022 | -25.55% |
| Sep 30, 2022 | -28.48% |
| Jun 30, 2022 | -30.08% |
| Mar 31, 2022 | -35.03% |
| Dec 31, 2021 | -23.48% |
| Sep 30, 2021 | -61.27% |
| Jun 30, 2021 | -36.91% |